Related Experiment Video
Updated: Jul 6, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Ildiko Bock-Marquette1, Ankur Saxena, Michael D White
1Department of Pediatrics, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA.
Thymosin beta4 peptide enhances cardiac cell migration and survival, promoting heart repair. This peptide activates a key pathway, offering a potential new therapeutic target for acute myocardial damage.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Molecular Cardiology
Background:
- Heart disease is a major cause of mortality in both neonates and adults.
- Current cardiac repair strategies often rely on stem cell transplantation.
- The need for novel therapeutic targets for myocardial repair is critical.
Purpose of the Study:
- To investigate the role of thymosin beta4 (Tβ4) in promoting cardiac cell migration and survival.
- To elucidate the molecular mechanisms underlying Tβ4's effects on cardiomyocytes.
- To evaluate Tβ4's therapeutic potential in a mouse model of myocardial infarction.
Main Methods:
- Assessed Tβ4's effects on embryonic and postnatal cardiomyocyte migration and survival in vitro.
- Investigated the interaction of Tβ4 with PINCH and integrin-linked kinase (ILK).
- Utilized a mouse model of coronary artery ligation to study Tβ4 treatment in vivo.
Main Results:
- Tβ4 significantly promoted myocardial and endothelial cell migration and enhanced cardiomyocyte survival.
- Tβ4 formed a complex with PINCH and ILK, activating the Akt (protein kinase B) survival pathway.
- In vivo, Tβ4 treatment upregulated ILK and Akt activity, improved myocyte survival, and enhanced cardiac function post-myocardial infarction.
Conclusions:
- Thymosin beta4 facilitates cardiomyocyte migration, survival, and cardiac repair.
- The Tβ4-regulated pathway involving PINCH, ILK, and Akt represents a promising therapeutic target for acute myocardial damage.
- Tβ4 demonstrates potential as a novel therapeutic agent for heart repair.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: